| __timestamp | Johnson & Johnson | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 22746000000 | 54823000000 |
| Thursday, January 1, 2015 | 21536000000 | 76691000000 |
| Friday, January 1, 2016 | 21685000000 | 87477000000 |
| Sunday, January 1, 2017 | 25354000000 | 89052000000 |
| Monday, January 1, 2018 | 27091000000 | 100745000000 |
| Tuesday, January 1, 2019 | 27556000000 | 91915000000 |
| Wednesday, January 1, 2020 | 28427000000 | 95905000000 |
| Friday, January 1, 2021 | 23402000000 | 104442000000 |
| Saturday, January 1, 2022 | 24596000000 | 104437000000 |
| Sunday, January 1, 2023 | 26553000000 | 112009000000 |
| Monday, January 1, 2024 | 27471000000 | 121134000000 |
Data in motion
In the ever-evolving landscape of the healthcare and retail sectors, Johnson & Johnson and Walgreens Boots Alliance, Inc. stand as titans. From 2014 to 2023, these companies have showcased distinct trends in their cost of revenue. Johnson & Johnson, a leader in pharmaceuticals and consumer health products, saw a steady increase in costs, peaking in 2020 with a 32% rise from 2014. Meanwhile, Walgreens Boots Alliance, a retail pharmacy powerhouse, experienced a more dramatic surge, with costs nearly doubling by 2023. This reflects their aggressive expansion and adaptation strategies. Notably, 2024 data for Johnson & Johnson is missing, hinting at potential shifts or reporting delays. As these giants navigate the complexities of their industries, understanding their financial trajectories offers valuable insights into their strategic priorities and market dynamics.
Comparing Cost of Revenue Efficiency: Eli Lilly and Company vs Johnson & Johnson
Johnson & Johnson vs Merck & Co., Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Amgen Inc.
Cost of Revenue Trends: Johnson & Johnson vs Neurocrine Biosciences, Inc.
Johnson & Johnson vs Walgreens Boots Alliance, Inc.: Annual Revenue Growth Compared
Cost Insights: Breaking Down Johnson & Johnson and PTC Therapeutics, Inc.'s Expenses
Cost of Revenue: Key Insights for Johnson & Johnson and Mesoblast Limited
Cost of Revenue Trends: Johnson & Johnson vs Viridian Therapeutics, Inc.
Cost of Revenue: Key Insights for Walgreens Boots Alliance, Inc. and Cytokinetics, Incorporated
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Supernus Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Wave Life Sciences Ltd.
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Taro Pharmaceutical Industries Ltd.